Uncovering New Solutions to Promote Health, Engagement AND Hope: 
What we KNOW from 2020 & 2021 and What we THINK we can expect in 2022  

Date: October 6, 2021
Time: 
8:30 am - 11:30 am (Program) | 11:30 am - 12:00 pm (Networking)
Type: Virtual Program
Registration Fee:* $175 Member | $225 Non-member

Register Now or call 781-684-8700 for more information


COVID-19 created statistically significant delays in most standard medical prevention screenings, particularly those related to early detection for cancers.  New health concerns, increased caregiving demands, fluctuating return-to-work plans, vaccine mandates, remote work pivots and feelings of isolation gave rise to considerable mental health issues often unmet or delayed due to access-to-care limitations.

Navigating these new unknowns and issues about employee population risks requires new approaches to avoid disruption and control health care cost.  Hear from a medical director, data analytics expert and health care panelists about what they see happening behind the scenes and what we know is likely to occur in 2022.

Attend this program to:

  • Learn the effects of COVID on population health, screenings, and prevention, as well as options to monitor and engage going forward.

  • Understand key data analytics associated with employer utilization to make informed decisions and devise new strategies for 2022.

  • Discover emerging innovations in cancer, mental health, and vaccination.

  • Get hands-on experience using data through facilitated case study and breakout sessions.

Bonus: All registrants will receive Merck’s Lung Cancer Screening Tool! 


Speakers:

  • Jenny S. Chiang, MD, MS, FAAFP – Medical Director, MetroWest Healthcare Alliance, Inc., Medical Director, Wellforce

  • Marilyn Schlein Kramer – Partner, Strategic Benefit Advisors

Panelists:

  • Kirsten Anderson, MD, MPH, CHIE – Senior Director Clinical Solutions for New England, Clinical Lead, Aetna Infectious Disease Advisory Team, Aetna/CVS Health

  • Tera Feldman, PA-C – Clinical Lead for Dana-Farber Direct Connect, Dana-Farber Cancer Institute

  • Rebecca Schechter – CEO of Optum Behavioral Health, Optum

Moderated by Patricia Rich, Vice President, Sales, Existing Business, AllWays Health Partners


Intended Audience:

  • HR, Benefits, Wellness professionals

  • Population Health Analysts

  • Population Health Managers

  • Any health and wellness professional who uses data analytics

 Don’t miss this opportunity to stay ahead of experts’ predictions
on what the COVID-19 pandemic will bring in 2022 and beyond!

Register Now 

Thank You to Our Program Sponsors



 


*Due to the current economic climate caused by the pandemic, NEEBC has not increased the fee for this Solutions program.

Educational sessions at this program may qualify for CEBS Compliance credit. Visit www.cebs.org/compliance for additional information.